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Background: The aim of this study was to evaluate and compare the postoperative effect of a topic gel containing 
chlorhexidine, chitosan, allantoine and dexpanthenol versus a placebo for pain and inflammation control after 
third molar surgery.
Material and Methods: A gel combining 0.2% chlorhexdine, 0.5% chitosan, 5% dexpanthenol, 0.15% allantoin and 
0.01% sodium saccharin was selected for this split mouth randomized controlled and double-blind trial includ-
ing 36 patients with bilaterally and symmetrically impacted lower third molars. The teeth (n=72) were randomly 
divided into two groups before surgical removal: control group (CG; in which a placebo was given) and experi-
mental group (EG). Swelling, trismus, postoperative pain, wound healing and complications were measured and 
recorded in order to evaluate differences between the placebo and experimental product.
Results: Five patients suffered from an alveolitis in the CG (13.9%), and none in the study group (0%), but no sta-
tistically significant difference was found (p=0.063). From day 0 to day 7, trismus and swelling were significantly 
less pronounced in the EG, and wound healing was considered ‘good’ in 22.2% for the CG and 97.2% for the EG 
(p<0.001). Mean VAS scores during the seven postoperative days were statistically lower in the study (2.56±1,19) 
compared to the placebo group (3.25±1.6) (p=0.002). The mean consumption of analgesic pills during the first 92 
hours was also statistically lower in the EG (0.26±0.51) in comparison to the CG (0.56±0.67) (p=0.003).
doi:10.4317/medoral.23661
Sáez-Alcaide LM, Molinero-Mourelle P, González-Serrano J, Ru-
bio-Alonso L, Bornstein MM, López-Quiles J. Efficacy of a topical gel 
containing chitosan, chlorhexidine, allantoin and dexpanthenol for pain 
and inflammation control after third molar surgery: A randomized and 
placebo-controlled clinical trial. Med Oral Patol Oral Cir Bucal. 2020 Sep 
1;25 (5):e644-51.
Article Number:23661          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
e645
Med Oral Patol Oral Cir Bucal. 2020 Sep 1;25 (5):e644-51. Chitosan based gel after third molar surgery
have antiseptic, anti-inflammatory and tissue repairing 
properties (12), it has been suggested that this topical 
gel could have beneficial effects on postoperative heal-
ing after third molar surgery. To our knowledge, no pre-
vious studies comparing this product versus placebo in 
the postoperative period after surgical removal of lower 
third molars have been performed.
The aim of this study is to evaluate the effect of a topical 
gel that contains 0.2% chlorhexidine, chitosan, allanto-
in and dexpanthenol compared to placebo in terms of 
pain, swelling and wound healing after third molar sur-
gery. The null hypothesis was that there is no difference 
between the topical gel (test) and placebo (control) for 
postoperative outcomes (pain, swelling, trismus, wound 
healing) after lower third molar surgery.
Material and Methods
This randomized and controlled clinical trial was de-
signed following CONSORT guidelines (15). The proto-
col was evaluated and approved by the Research Ethics 
Committee at the Clínico San Carlos Hospital of Ma-
drid, Spain (Trial registration code CEIC 17/386-R_X). 
Informed consent was obtained from all participants in 
writing prior to conducting the research.
- Patient selection
The patients were selected from those attending the 
Postgraduate Clinic in Oral Surgery and Implant Den-
tistry, Faculty of Dentistry, at Complutense University 
of Madrid between January 2018 and May 2019 until 
the required sample was obtained. The screening ex-
amination included the following: medical and dental 
questionnaire, standardized panoramic radiograph 
made at the Dental Radiology Service, Faculty of Den-
tistry, Complutense University of Madrid (CS 9300®, 
Carestream Dental, Atlanta, GA, USA), and signed in-
formed consent.
To be included in the study the subjects had to fulfill 
the following inclusion criteria: aged 18 years or old-
er, patients ASA 1 according to the American Society 
of Anesthesiologists classification (16), indication of 
lower third molar surgery, similar surgical difficulty on 
both sides according to Pederson scale (17), no known 
allergies to any of the gel components (chitosan, clo-
rhexidine, allantoin, dexpanthenol), the medications 
prescribed (amoxicillin, ibuprofen, dipyrone) and the 
anesthetic solution used (4% articaine with 1:100,000 
adrenaline).
Introduction
Third molar surgery has been described as the most 
common procedure in oral surgery and the postopera-
tive phase is commonly identified unpleasant by pa-
tients (1-3). During the healing period, patients might 
experience pain, swelling and trismus as the most com-
mon and typical symptoms. Other complications such 
as alveolar osteitis (dry socket), excessive bleeding or 
neurosensorial alterations have also been widely de-
scribed (3,4).
To reduce these symptoms and/or complications, vari-
ous topical medications or gels have been suggested 
and investigated. Among others, chlorhexidine as an 
antiseptic gel or rinse has been shown to reduce these 
complications (4-7). Chlorhexidine has been specifi-
cally studied due to its antibacterial activity and has 
been demonstrated to reduce alveolitis between 24.5 
to 80.2% (8). However, chlorhexidine gel application in 
the wound has been used by different authors without 
been able to find differences between chlorhexidine and 
placebo in terms of dry socket development and pain 
and swelling improvement after third molar surgery 
(7,8). Because of these contradictory results, chlorhexi-
dine has been combined with other products to increase 
overall efficacy in more recent studies (9,10).
Chitosan is a natural polymer that comes from chitin. 
Its natural qualities make chitosan biodegradable, bio-
compatible, hemostatic, antioxidative, antibacterial, and 
mucoadhesive. These properties seem to be very useful 
in the control of postoperative complications of third 
molar surgery (11-13). The hemostatic benefits of chito-
san in dressings are marketed for example as HemCon 
Dental Dressing (HDD; HemCon Medical Technolo-
gies, Inc, Beaverton, OR). The control of postoperative 
hemostasis following oral surgery procedures using this 
product has already been described (14). On the other 
hand, it is known that chitosan can be useful in reduc-
ing postoperative pain and inflammation, as well as 
decreasing bacterial proliferation after periodontal and 
peri-implant disease treatment (12). In addition, recent 
pre-clinical studies suggest that chitosan gel generates a 
protective hydrolipidic layer that prevents and improves 
tissue perfusion, thus promoting tissue regeneration and 
providing anti-inflammatory characteristics (13).
Recently, a topical gel that contains 0.2% chlorhexidine, 
chitosan, allantoin and dexpanthenol has been commer-
cialized. Since it is known that all these components 
Conclusions: The use of an experimental gel containing chlorhexidine, chitosan, allantoine and dexpanthenol seems 
to significantly reduce postoperative pain, trismus and signs of inflammation. Future studies should further evaluate, 
if the gel is effective in dry socket preventing after third molar removal. 
Key words: IThird molar, surgery, postoperative wound healing, pain, gel, chitosan, chlorhexidine, allantoin, dex-
panthenol.
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Exclusion criteria were as follows: patients who did not 
agree to participate in the study, patients who did not 
understand the procedures of the study, patients who 
did not come at 48 hours and at 7 days follow-up, smok-
ers (more than 10 cigarettes per day), patients treated 
with antibiotics or anti-inflammatory medication 4 days 
prior to the surgery, pregnant or lactating women and 
healthy periodontally patients with no residual pockets 
> 4 mm.
- Sample size calculation
The sample size was calculated similarly to the study by 
Haraji et al. (18) that used a 0.2% clorhexidine bioadhe-
sive gel in comparison to a placebo for the prevention of 
alveolar osteitis after mandibular third molar surgery. 
For the present study, it was estimated that less than 
5% of the study group would suffer from an alveolitis. 
Thus, it was estimated that 32 patients in each group 
would be required to obtain 90% power to detect this 
effect as statistically significant (α=0.05). As a 15% loss 
to follow-up was assumed, the number of subjects per 
group to reach the objectives was indicated as 74, i.e. 
37 per group since this investigation is conceived as a 
split-mouth study.
- Study design
To assess the differences between the placebo and the 
experimental product, a split-mouth randomized pla-
cebo-controlled trial was conducted. Once included, 
lower third molars interventions of the patients were 
randomly divided through a digital platform (Viedoc©, 
Pharma Consulting Group, Uppsala, Sweden). Prior to 
the surgical procedure, one blinded examiner (P.M.M.) 
recorded the baseline data, including the following: rea-
son for the surgery, interincisal distance measured in 
millimeters to evaluate trismus, and facial perimeter to 
analyze postoperative swelling according to Amin and 
Laskin (19), which measures the changes in millimeters 
before and after surgery between different facial points 
including the distance from gonion to the external can-
thus of the eye (Go-Eye), the distance from tragus to 
the labial commissure (Tg-Com), and the distance from 
tragus to pogonion (Tg-Pg).
- Surgical procedure
All surgical procedures were conducted by a single 
surgeon (L.M.S.A.) between 8:00 am and 11:00 am. A 
minimum of one month was allowed between one sur-
gery and the intervention on the contralateral side. The 
anesthetic used for all interventions was 4% articaine 
with 1:100,000 adrenaline (Laboratorios Normon; Tres 
Cantos, Madrid, Spain).
An envelope-shape incision from the lower second mo-
lar with a vertical releasing incision on the ramus was 
made, and a mucoperiosteal flap was raised to expose 
the lower third molar. No. 8 tungsten carbide bur on a 
surgical handpiece was used to perform bone removal 
and, if necessary, to section the molar. After the tooth 
extraction, bony edges were smoothened, and the wound 
was irrigated with copious use of saline solution. Then, 
the flap was sutured with simple interrupted sutures us-
ing 4.0 silk (Laboratorio Aragó S.A.; Barcelona, Spain).
According to the previously prepared randomization, 
experimental gel or placebo were applied on the wound 
(14). Finally, the surgeon filled out the data collection 
sheet using the vial code for further processing. Surgery 
time, surgery difficulty according to Parant scale (18), 
and surgical complications were also recorded.
Patients were prescribed amoxicillin 750 mg to be taken 
every 8 hours for 7 days, and Ibuprofen 600 mg every 8 
hours for 4 days. They were also prescribed 575 mg of 
dipyrone for use as a rescue analgesic as need.
- Follow-up
During the postoperative week, patients in the experi-
mental group applied topical gel composed of chitosan, 
0.2% chlorhexidine, allantoin and dexpanthenol (Bexi-
dent® Post Tratamiento Gel Tópico, ISDIN S.A.; Barce-
lona, Spain) on the surgical wound. 
Patients in the control group applied the placebo gel, 
which was manufactured from a master pharmacological 
formulation including all the components from the com-
mercially available gel with the exception of chitosan, 
0.2% chlorhexidine, allantoin and dexpanthenol. Patients 
in both groups applied the gel three times a day for 7 days.
During the follow-up periods at 48 hours and 7 days the 
examiner (P.M.M.) recorded the following data: facial 
perimeter measures and interincisal distance to evalu-
ate changes compared to baseline, the wound healing 
using a modified scale according to Madrazo-Jimenez 
et al. (14) (Table 1), presence of alveolar osteitis accord-
ing to the Blum criteria (20), and infectious, hemor-
rhagic or neurosensorial complications. Postoperative 
pain was measured using a visual analog scale (VAS) 
from 0 to 10, where 0 supposes no pain and 10 the worst 
possible pain, during the first seven postoperative days. 
Furthermore, the number of rescue analgesic taken dur-
ing the first four days after surgery were recorded.
Table 1: Scale used to evaluate wound healing.
Good Acceptable Bad






Color of the mucose Identical to the surrounded mucosa Similar to the surrounded mucosa Erythematous
Wound clousure Complete 1-2 mm of dehiscence >3 mm dehiscencce
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- Statistical analysis
Descriptive parameters (frequency, mean and standard 
deviation) of the variables were calculated. For the 
quantitative variables (facial perimeter, trismus, post-
operative pain), the Student’s T test for paired samples 
and the Wilcoxon signed-rank test were used. For the 
categorical (ordinal) variables (surgery difficulty, pres-
ence of alveolar osteitis and wound healing), the McNe-
mar and Wilcoxon tests were performed (p<0.05).
The significance level chosen for all statistical tests was 
p<0.05. Statistical analyses were all performed using 
the IBM SPSS Statistics v.25 software (IBM, United 
States).
Results
Forty patients were recruited to participate in this study. 
Thirty-six patients completed the study (23 women and 
13 men; mean age 22.94±2.67 years). Two patients of the 
placebo group did not want to perform the second left or 
right third molar surgery, and two patients did not come 
to the follow-up visits in the study group. Therefore, these 
patients were excluded from further analyses (Fig. 1). Age 
and gender were the same for both groups, since a split-
mouth design was performed. The surgical difficulty of the 
third molars and the time for the surgical interventions are 
shown in Table 2. In this study, the duration of the surger-
ies did not exceed 30 minutes for any of the cases included.
Table 2: Characteristics of patients and surgical variables analysed.
Fig. 1: Flowchart diagram of the study protocol according to Consort guidelines.
Patient sample 
(n=36) Third molar sample (n=72) p
Placebo (n=36) Experimental (n=36) -
Age (years) 22.94±2.67 -
Sex
Male 13/36 (36.11%) -
Female 23/36 (63.89%) -
Tooth extracted
38 20/36 (55,55%) 17/36 (47,22%) 0.025
48 16/36 (44,44%) 19/36 (52,77%) 0.034
Pederson scale 6,16±1,15 6,25±1,13 0.27
Surgical time 
(seconds) 702.18±349.68 688.74±382.76 0.362
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- Clinical outcomes
Alveolitis
The presence of an alveolitis was reported in 5 out of 
36 sockets (13.9%) in the placebo, and none (0%) was 
recorded for the study group (p=0.063).
Swelling
Mean changes for facial swelling from baseline to the 
visit at 48 hours and 7 days after surgery are present-
ed in Table 3. Statistically, lower differences were ob-
served for Tg-Pg values in the study group compared 
to the control group between baseline and the 48 hours 
visit (p=0.023). Trismus and all three swelling mea-
surements showed significantly lower values in the 
study group compared to the control patients from day 
0 to day 7 (Go-Eye, p=0.009; Tg-Com, p<0.001; and 
Tg-Pg, p<0.001). 
Wound healing
Two days after surgical removal of the lower third mo-
lars, wound healing was considered “bad” in 25% and 
0%, “acceptable” in 75% and 58.3%, and “good” in 
0% and 41.7% of the sockets in the placebo and study 
groups (p<0.001), respectively (Fig. 2). Seven days af-
ter surgery, wound healing was considered “bad” in 0% 
and 0%, “acceptable” in 77.8% and 2.8%, and “good” in 
22.2% and 97.2% of the cases for the placebo and study 
groups (p<0.001), respectively (Fig. 2).
Pain
The mean VAS values for the 7 days following surgical 
removal were 3.25±1.6 and 2.56±1.19 in the placebo and 
study groups (p=0.002), respectively (Fig. 3). A mean 
consumption of 0.56±0.67 and 0.26±0.51 analgesic pills 
per day was recorded for the placebo and study groups 




Day 0 Day 2 Day 7 Day 2-Day 0 Day 7-Day 0 Day 2-Day 7













Test 36 50.15 4.86 35.83 8.02 45.64 6.21 -14.32 6.49 -4,52 4,38 -9.81 5.02
Go-Eye






Test 36 10.88 0.71 11.61 0.81 11.06 0.67 0.73 0.49 0,18 0,16 0.54 0.38
Tg-Com






Test 36 11.45 0.53 12.04 0.57 11.58 0.53 0.59 0.34 0,13 0,16 0.46 0.28
Tg-Pg






Test 36 15.39 0.91 16.14 0.85 15.54 0.84 0.75 0.35 0,15 0,15 0.60 0.34
Go-Eye: Distance from gonion to the external canthus of the eye. Tg-Com: Distance from tragus to labial commissure. Tg-Pg: Distance from 
tragus to pogonion.
Table 3: Mean and standard deviations (SD) of mouth opening and facial perimeter in test and placebo groups during the postoperative period.
- Complications and adverse effects
For the test group, one case of hematoma was reported. 
In the placebo group, 3 patients with hematoma and 
cases and finally 1 case with temporary paraesthesia of 
the inferior alveolar nerve were seen.
Discussion
The aim of this study was to evaluate the efficacy of 
a topical gel containing 0,2 % chlorhexidine, chitosan, 
allantoine and dexpanthenol compared to a placebo in 
the postoperative healing period after lower third molar 
surgery. To the best of our knowledge, this is the first 
study published that compares this product versus a pla-
cebo. However, there are some limitations of the pres-
ent study that should be considered for further studies Fig. 2: Wound healing during the postoperative period.
Fig. 3: VAS scores from day 0 to day 7 in each group.
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on this topic. The assessment of the clinical outcomes, 
especially pain and wound healing, has been done using 
subjective scales, which could be conceived as biased. 
Moreover, further studies should focus on analyzing 
the role of the gel tested on postoperative swelling and 
should also include a longer follow-up period.
Moreover, a longer follow-up period would be better in 
order to analyze in more detail the evolution of the clini-
cal results, especially the development of alveolitis (6).
It has been reported in the literature that time is relevant 
in oral surgery, and that there is a direct relationship 
between the increase in postoperative inflammation 
and pain and a prolonged duration of the procedures. 
Therefore, this will also impact on the subsequent heal-
ing process (3). In the present study, the longest surgery 
lasted for 25.30 minutes, which is not considered over 
the limit of 30 minutes (3,21).
The most striking differences between the two groups 
analyzed were found in wound healing and postopera-
tive pain with better results for the experimental group. 
Although there were no significant differences between 
groups with regard to alveolar osteitis, our results sug-
gest that the experimental product could be effective in 
alveolar osteitis prevention as there have been no cases 
of alveolitis in the experimental group.
The antiseptic effect of topic chlorhexidine in the oral 
cavity is well documented and improved wound heal-
ing and a preventive effect with regard to alveolar os-
teitis has been demonstrated after topic application of 
chlorhexidine gel or rinses following third molar sur-
gery (22,23). Chitosan has also antiseptic action due to 
its antimicrobial power against gram-negative, gram-
positive bacteria and fungi. In recent years, tissue re-
pairing properties have also been documented for chi-
tosan, which could be promising for periodontal/guided 
bone regeneration (24). Furthermore, dexpanthenol has 
been widely studied in the field of dermatology, where 
in vivo and in vitro studies have demonstrated a positive 
effect on the proliferation of human fibroblast, which 
could result in improved soft tissue healing (25). All 
these favorable findings of antiseptic and tissue repair 
capacities attributed to chlorhexidine, chitosan and dex-
panthenol could be directly related to an improvement 
in wound healing after third molar surgery, which could 
explain the results seen in the present study.
However, despite the positive effect of these compo-
nents, it is not possible to assume that the topical ap-
plication of the gel tested would have enough power to 
result in any evident systemic effects.
At the second day, 25% of the cases (9 patients) in the 
placebo group showed “bad” (unsatisfactory) healing 
compared to the experimental group that showed only 
“acceptable” or “good” wound healing. All the previous 
mentioned properties of the experimental gel could ex-
plain these differences. Nevertheless, the method cho-
sen here to evaluate wound healing could be rather sub-
jective, and therefore, the results should be interpreted 
with some caution.
As for bad (unsatisfactory) wound healing, alveolar os-
teitis was observed only in the placebo group (19,3%), 
but not in the experimental group. Although significant 
differences were not found between groups, the preven-
tive effect of chlorhexidine in terms of dry socket and 
the antiseptic effect of chitosan could explain these re-
sults. Moreover, the 5 patients who developed alveolar 
osteitis in the control group were in need of extended 
surgical procedures including bone more removal and 
tooth sectioning due to the deeper position of the third 
molars. Here, the mean surgical time was 20:34 min-
utes. These factors could also at least partially explain 
the differences seen between the two groups.
Regarding other complications, a transitory paresthesia 
of the inferior alveolar nerve was observed in the con-
trol group. The patient presented a very deep impacted 
third molar with a direct relation to the inferior alveolar 
nerve. Extended bone removal including crown and root 
sectioning were needed to remove the tooth. This in-
tervention lasted for 22:43 minutes from incision to su-
turing. This could very likely explain the complication 
seen. For the paresthesia, no treatment was needed, and 
total recovery was recorded 14 days after surgery. Addi-
tionally, 4 cases of hematoma were seen, two of them in 
the same patient. In all these cases, the surgeries includ-
ed bone removal and tooth sectioning were needed, and 
the interventions lasted 15:32 minutes (mean). Thus, the 
complications mentioned here do not seem to have a 
direct relation with the application of either placebo or 
experimental product, but rather with difficulty of the 
surgery itself and the surgical time needed.
Similar results to ours have been published in the study 
of Madrazo-Jimenez et al. (14). In this research they 
applied a gel containing chitosan in the experimental 
group but did not use a placebo in the control group. As 
our results, the authors found a statistically significant 
difference for wound healing in favour of the experi-
mental group. However, they did not find differences in 
terms of pain between the groups. One reason that may 
explain this discrepancy is the subjectivity and individ-
ual variability of pain assessment using VAS that can 
result in different findings especially for studies with 
limited power.
López-López et al. also evaluated the effect of this gel 
following third molar surgery in a randomized con-
trolled study comparing the efficacy of this product 
compared to a bicarbonate oral rinse (13). In terms of 
pain, they found better results in favor of the gel con-
taining chitosan with significant differences for VAS 
values and analgesic intake. Likewise, better wound 
healing was recorded for the experimental group. These 
clinical findings were very similar to the ones recorded 
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in the present study. Based on these results, it seems 
possible that this product could be effective in reducing 
postoperative pain and improving wound healing after 
surgical removal of third molars.
Several products have been used to improve healing and 
reduce complications after surgical third molar extrac-
tion. Chlorhexidine is probably the most studied anti-
septic in this sense. Rodríguez-Sánchez et al. carried 
out a systematic review and they concluded that both 
chlorhexidine rinse and gel application was effective 
to prevent alveolar osteitis after third molar extraction 
(22). Similar results were found in another systematic 
review published one year later, in which it was con-
cluded that chlorhexidine gel application was superior 
to placebo in reducing the incidence of alveolitis after 
mandibular third molar surgery (23). Despite all these 
positive properties, several side effects such as discol-
oration of teeth and oral mucosa, a burning sensation or 
taste disturbances have been attributed to chlorhexidine 
(26). These aspects should be considered when pre-
scribing it after third molar surgery. In view that the gel 
tested does not only contain chlorhexidine but also oth-
er components which improve clinical outcomes, such 
a more wholistic formulation could be more complete 
and effective to prevent and reduce complications after 
third molar surgery including impaired wound healing 
or postoperative pain.
Povidone-iodine or Betadine is another of the most 
widely used antiseptic agents in surgery. Hasheminia et 
al. conducted a clinical study with 189 patients in which 
they compared the efficacy of 1% betadine solution rins-
es versus a control group without any antiseptic. The re-
sults showed a significant difference between groups in 
favor of betadine rinses for the incidence of dry socket 
formation after third molar surgery. However, there is 
no evidence that betadine also improves wound healing 
and decreases postoperative pain (27). Therefore, the 
experimental gel used here could be more effective than 
betadine after third molar surgery.
Hialuronic acid has also been widely applied in daily 
practice after third molar surgery. Koray et al. evalu-
ated the efficacy of hyaluronic acid spray versus ben-
zydamine hydrochloride in reducing swelling, pain and 
trismus after mandibular third molar surgery. Although 
they found no evidence of a reduction in pain levels be-
tween groups, hyaluronic acid offered clinical benefits 
in the management of swelling and trismus for the im-
mediate postoperative period. In their study, none of the 
patients develop an alveolar osteitis in any of the groups. 
These findings may be directly related to repairing tis-
sue properties of hyaluronic acid, which could improve 
wound healing and, in consequence, reducing inflam-
mation (28). Although the positive properties of hyal-
uronic acid on tissue repair are well documented, the 
tested experimental product seems to be more effective 
after third molar surgery by not only improving wound 
healing but also preventing alveolar osteitis.
Propolis is a natural product substance obtained from 
beehives, and it has been attributed with anti-bacterial, 
anti-fungal and anti-inflammatory properties. In the 
field of oral surgery, it has been demonstrated to have 
positive effects in the treatment of oral aphthous ul-
cers and in the prevention of bacterial colonization on 
sutures after oral surgery (29,30). To the best of our 
knowledge, there are no studies that have evaluated its 
effectiveness after third molar surgery. Therefore, fur-
ther studies on this topic are needed, and a gel contain-
ing propolis cannot be an alternative at the moment to 
the gel tested here.
Conclusions
Based on the findings of the present study, the tested 
topical gel containing 0.2% chlorhexidine, chitosan, al-
lantoin and dexpanthenol results in a significant reduc-
tion of postoperative pain, trismus and inflammation 
compared to the placebo used. Furthermore, improved 
wound healing capacities can be seen in the experimen-
tal group.
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